Vistacare Medical and Quantum Genomics enter into exclusive negotiations with the ambition of creating a reference player in the management of complex wounds

20 July 2023by admin-vistacare

VistaCare Medical, a French medtech company developing innovative technology for the treatment of complex wounds, and Quantum Genomics, a biopharmaceutical company listed on the Euronext Growth market in Paris, have entered into exclusive negotiations to create a leading player in the field of complex wound management.

For more information please see our press release. Press release – VistaCare Medical and Quantum Genomics merger – July 2023 

 
 
Ce site est réservé aux professionnels de santé.

Êtes-vous un professionnel de santé ?

 
 
The site is reserved for healthcare professionals.

Are you a healthcare professional ?